These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28330995)

  • 1. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
    Pyzik M; Rath T; Kuo TT; Win S; Baker K; Hubbard JJ; Grenha R; Gandhi A; Krämer TD; Mezo AR; Taylor ZS; McDonnell K; Nienaber V; Andersen JT; Mizoguchi A; Blumberg L; Purohit S; Jones SD; Christianson G; Lencer WI; Sandlie I; Kaplowitz N; Roopenian DC; Blumberg RS
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2862-E2871. PubMed ID: 28330995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway.
    Chia J; Louber J; Glauser I; Taylor S; Bass GT; Dower SK; Gleeson PA; Verhagen AM
    J Biol Chem; 2018 Apr; 293(17):6363-6373. PubMed ID: 29523681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Glycan Moieties in Neonatal Fc Receptor Determine Steady-state Membrane Distribution and Directional Transport of IgG.
    Kuo TT; de Muinck EJ; Claypool SM; Yoshida M; Nagaishi T; Aveson VG; Lencer WI; Blumberg RS
    J Biol Chem; 2009 Mar; 284(13):8292-300. PubMed ID: 19164298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy gene
    Uchida Y; Torisu K; Ueki K; Tsuruya K; Nakano T; Kitazono T
    Am J Physiol Renal Physiol; 2021 Nov; 321(5):F572-F586. PubMed ID: 34541900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
    Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
    MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.
    Schmidt EGW; Hvam ML; Antunes F; Cameron J; Viuff D; Andersen B; Kristensen NN; Howard KA
    J Biol Chem; 2017 Aug; 292(32):13312-13322. PubMed ID: 28637874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement.
    Larsen MT; Rawsthorne H; Schelde KK; Dagnæs-Hansen F; Cameron J; Howard KA
    J Control Release; 2018 Oct; 287():132-141. PubMed ID: 30016735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions.
    Sockolosky JT; Tiffany MR; Szoka FC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16095-100. PubMed ID: 22991460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal FcRn reclaims albumin but facilitates elimination of IgG.
    Sarav M; Wang Y; Hack BK; Chang A; Jensen M; Bao L; Quigg RJ
    J Am Soc Nephrol; 2009 Sep; 20(9):1941-52. PubMed ID: 19661163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FcRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages.
    Toh WH; Louber J; Mahmoud IS; Chia J; Bass GT; Dower SK; Verhagen AM; Gleeson PA
    J Cell Sci; 2019 Oct; 133(5):. PubMed ID: 31444284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies.
    Sand KM; Dalhus B; Christianson GJ; Bern M; Foss S; Cameron J; Sleep D; Bjørås M; Roopenian DC; Sandlie I; Andersen JT
    J Biol Chem; 2014 Jun; 289(24):17228-39. PubMed ID: 24764301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding.
    Andersen JT; Dalhus B; Viuff D; Ravn BT; Gunnarsen KS; Plumridge A; Bunting K; Antunes F; Williamson R; Athwal S; Allan E; Evans L; Bjørås M; Kjærulff S; Sleep D; Sandlie I; Cameron J
    J Biol Chem; 2014 May; 289(19):13492-502. PubMed ID: 24652290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
    Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption.
    Swiercz R; Mo M; Khare P; Schneider Z; Ober RJ; Ward ES
    Oncotarget; 2017 Jan; 8(2):3528-3541. PubMed ID: 27974681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling.
    Merten H; Brandl F; Zimmermann M; Schaefer JV; Irpinio L; Sand KMK; Nilsen J; Andersen JT; Zangemeister-Wittke U; Plückthun A
    Eur J Pharm Biopharm; 2021 Oct; 167():104-113. PubMed ID: 34303832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic functions of the neonatal Fc receptor for IgG.
    Rath T; Kuo TT; Baker K; Qiao SW; Kobayashi K; Yoshida M; Roopenian D; Fiebiger E; Lencer WI; Blumberg RS
    J Clin Immunol; 2013 Jan; 33 Suppl 1(Suppl 1):S9-17. PubMed ID: 22948741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical chemistry of human FcRn transgenic mice.
    Stein C; Kling L; Proetzel G; Roopenian DC; de Angelis MH; Wolf E; Rathkolb B
    Mamm Genome; 2012 Apr; 23(3-4):259-69. PubMed ID: 22193411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
    Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
    J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Humanized Mouse Model to Study Human Albumin and Albumin Conjugates Pharmacokinetics.
    Low BE; Wiles MV
    Methods Mol Biol; 2016; 1438():115-22. PubMed ID: 27150087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins.
    Chung S; Lin YL; Nguyen V; Kamen L; Zheng K; Vora B; Song A
    J Immunol Methods; 2018 Nov; 462():101-105. PubMed ID: 30030147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.